Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0528 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.015 | 0.0087 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0528 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0023 | 0.0064 | 0.0067 |
Plasmodium falciparum | LCCL domain-containing protein | 0.0023 | 0.0064 | 0.0067 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.015 | 0.02 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.015 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.037 | 0.6484 | 1 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.037 | 0.6484 | 1 |
Onchocerca volvulus | 0.0028 | 0.015 | 1 | |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.015 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0561 | 1 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.015 | 0.02 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0028 | 0.015 | 0.02 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0028 | 0.015 | 0.02 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0028 | 0.015 | 0.0232 |
Mycobacterium ulcerans | hypothetical protein | 0.0028 | 0.015 | 0.02 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.015 | 0.013 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.037 | 0.6484 | 1 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.015 | 0.0087 |
Loa Loa (eye worm) | doublecortin family protein | 0.0023 | 0.0064 | 0.0043 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0064 | 0.083 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.015 | 0.5 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.015 | 0.0087 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0528 | 1 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0028 | 0.015 | 0.0232 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.037 | 0.6484 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.015 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0528 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.015 | 0.013 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0064 | 0.0043 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.015 | 0.013 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0064 | 0.083 | 1 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0028 | 0.015 | 0.02 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.037 | 0.6484 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.015 | 0.02 |
Loa Loa (eye worm) | hypothetical protein | 0.0023 | 0.0064 | 0.0043 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0028 | 0.015 | 0.02 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.015 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.0064 | 0.083 | 1 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.037 | 0.6484 | 1 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.037 | 0.6484 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0021 | 0.0021 | 0.0032 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0528 | 1 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.037 | 0.6484 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 1 uM | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
IC90 (functional) | > 1 uM | DNDI: Inhibition of Chagas Disease parasite Trypanosoma cruzi (Tulahuen LacZ, Clone C4), in vitro. | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Trypanosoma cruzi | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.